NURSl 5334/l NURS5334l Examl 1l (NEWl
2026l Update)l –l Advancedl
Pharmacologyl Guidel |l Questionsl &l
Answersl |l Gradel A|l 100%l Correctl
(Verifiedl Solutions)-l UTA
QUESTION
Retapamulinl andl mupirocinl txl (TOPICALS)
Answer:
topicall treatmentl forl impetigo
QUESTION
Mupirocinl (topical)
Answer:
MRSAl inl nostrils
QUESTION
TBl treatment
Answer:
RIPEl (rifampin,l isoniazid,l pyrazinamide,l ethambutol);l rifapentinel andl rifabutin
QUESTION
TBl treatmentl isl effectivel when
,Answer:
nol mycobacterial inl sputuml andl nol coloniesl presentl inl culture
QUESTION
TBl secondl linel injectionl drugs
Answer:
Amikacinl &l Capreomycin
QUESTION
MDR-TB
Answer:
resistantl tol isoniazidl andl rifampin
QUESTION
XDR-TB
Answer:
resistantl notl onlyl tol isoniazidl andl rifampinl butl alsol tol anyl fluoroquinolonel andl atl leastl
onel ofl inject.l secondl linel drugs
QUESTION
TBl promotingl resistance
Answer:
Dailyl observedl therapyl (DOT),l intermittentl dosingl (2-3l times/week)
QUESTION
Txl ofl latentl TB
Answer:
, INHl (isoniazid)l dailyl forl 9l monthsl
ORl
INHl +l Rifampentinl forl 3l months
QUESTION
TBl Evaluation
Answer:
3l modes:l
-bacteriall evall ofl sputum
-clinicall eval.
-chestl radiographs
QUESTION
INHl adversel effects
Answer:
peripherall neuropathyl (vit.l b6,l pyridoxine),l hepatotoxicity,l anemia,l opticl neuritis
QUESTION
Isoniazidl BBW
Answer:
Canl causel hepatitisl andl death
QUESTION
Rifampinl adversel effects
Answer:
-Causesl discolorationl ofl bodilyl fluids
-GI
-cutaneousl rxn
-hepatotoxic/hepatitis
2026l Update)l –l Advancedl
Pharmacologyl Guidel |l Questionsl &l
Answersl |l Gradel A|l 100%l Correctl
(Verifiedl Solutions)-l UTA
QUESTION
Retapamulinl andl mupirocinl txl (TOPICALS)
Answer:
topicall treatmentl forl impetigo
QUESTION
Mupirocinl (topical)
Answer:
MRSAl inl nostrils
QUESTION
TBl treatment
Answer:
RIPEl (rifampin,l isoniazid,l pyrazinamide,l ethambutol);l rifapentinel andl rifabutin
QUESTION
TBl treatmentl isl effectivel when
,Answer:
nol mycobacterial inl sputuml andl nol coloniesl presentl inl culture
QUESTION
TBl secondl linel injectionl drugs
Answer:
Amikacinl &l Capreomycin
QUESTION
MDR-TB
Answer:
resistantl tol isoniazidl andl rifampin
QUESTION
XDR-TB
Answer:
resistantl notl onlyl tol isoniazidl andl rifampinl butl alsol tol anyl fluoroquinolonel andl atl leastl
onel ofl inject.l secondl linel drugs
QUESTION
TBl promotingl resistance
Answer:
Dailyl observedl therapyl (DOT),l intermittentl dosingl (2-3l times/week)
QUESTION
Txl ofl latentl TB
Answer:
, INHl (isoniazid)l dailyl forl 9l monthsl
ORl
INHl +l Rifampentinl forl 3l months
QUESTION
TBl Evaluation
Answer:
3l modes:l
-bacteriall evall ofl sputum
-clinicall eval.
-chestl radiographs
QUESTION
INHl adversel effects
Answer:
peripherall neuropathyl (vit.l b6,l pyridoxine),l hepatotoxicity,l anemia,l opticl neuritis
QUESTION
Isoniazidl BBW
Answer:
Canl causel hepatitisl andl death
QUESTION
Rifampinl adversel effects
Answer:
-Causesl discolorationl ofl bodilyl fluids
-GI
-cutaneousl rxn
-hepatotoxic/hepatitis